13 Feb 2017 14:04
13 February 2017
Kromek Group plc
("Kromek" or the "Company" or the "Group")
Director/PDMR Shareholding
Further to the announcement by the Company on 10th February 2017, Lawrence Kinet, a non-Executive Director of the Company, has confirmed to the Company that on the 10th February 2017 he acquired 50,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 22.9 pence per Ordinary Share. Following the purchase Mr Kinet is beneficially interested in 200,000 Ordinary Shares, representing 0.1 per cent. of the current issued share capital of the Company.
The Company has also today been informed by Jerel Whittingham, also a non-Executive Director of the Company, that due to an administrative error he did not subscribe for 4,029 Ordinary Shares under the Open Offer, as had been previously indicated. Mr Whittingham has indicated to the Company that he indends to purchase at least 4,029 Ordinary Shares in the open market in due course. A further announcement will be made on this purchase, as and when it occurs.
Enquiries
Kromek Group plc | 01740 626 060 |
Arnab Basu, CEO Derek Bulmer, CFO |
|
|
|
Cenkos Securities plc | 0207 397 8900 |
Bobbie Hilliam (NOMAD) Harry Pardoe |
|
|
|
Luther Pendragon | 0207 618 9100 |
Harry Chathli, Claire Norbury, Alexis Gore |
|
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Lawrence Kinet | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Non-Executive Director | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Kromek Group plc | ||||
b)
| LEI
| N/a | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 1p each
| ||||
b)
| Nature of the transaction
| Purchase of Ordinary Shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
50,000 Ordinary Shares
22.9p per Ordinary Share
| ||||
e)
| Date of the transaction
| 10 February 2017 | ||||
f)
| Place of the transaction
| London Stock Exchange | ||||
About Kromek Group plc
Kromek Group plc is a UK technology company (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT"). Using its core CZT technology, Kromek designs develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.
The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.
The Group's business model provides a vertically integrated technology offering to customers, from the growth of CZT crystals to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").
The Group has operations in the UK, Germany and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.
Currently, the Group has over a hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com.
Kromek (KMK)